Aref Zayed
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Pharmacogenetics and Drug Metabolism 3
- Piperaceae Chemical and Biological Studies 2
- Pharmacology and Obesity Treatment 2
- Co-authors
- Bashar Al-Taani (2 shared papers)Nida Alshraiedeh (1 shared paper)Nusaiba K. Al‐Nemrawi (1 shared paper)Tamam El‐Elimat (6 shared papers)Sahar Hawamdeh (3 shared papers)Barry L. Sharp (2 shared papers)George D.D. Jones (2 shared papers)Anne Thomas (2 shared papers)
- Journals
- Molecules (3 papers)Heliyon (2 papers)Pharmaceuticals (2 papers)International Journal of Mass Spectrometry (1 paper)Medicinal Chemistry Research (1 paper)
- Partner nations
- JordanUnited StatesUnited Kingdom
In The Last Decade
Aref Zayed
24 papers receiving 370 citations
Peers
Comparison fields: 5 of 87
- Pharmacology 87
- Pharmaceutical Science 59
- Analytical Chemistry 29
- Biomaterials 37
- Oncology 60
Countries citing papers authored by Aref Zayed
This map shows the geographic impact of Aref Zayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aref Zayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aref Zayed more than expected).
Fields of papers citing papers by Aref Zayed
This network shows the impact of papers produced by Aref Zayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aref Zayed. The network helps show where Aref Zayed may publish in the future.
Co-authors
The 25 scholars most cited alongside Aref Zayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 71 | |
| 2 | 2008 | 70 | |
| 3 | 2022 | 40 | |
| 4 | 2011 | 29 | |
| 5 | 2010 | 25 | |
| 6 | 2018 | 24 | |
| 7 | 2018 | 19 | |
| 8 | 2020 | 15 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 9 | |
| 12 | 2018 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2025 | 2 | |
| 20 | 2024 | 1 |
About Aref Zayed
Aref Zayed is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Oncology and Plant Science, having authored 27 papers that have together received 374 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Analytical Methods in Pharmaceuticals (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Piperaceae Chemical and Biological Studies (2 papers), Pharmacology and Obesity Treatment (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Pharmacology (87 citations), Pharmaceutical Science (59 citations), Analytical Chemistry (29 citations), Biomaterials (37 citations) and Oncology (60 citations). Aref Zayed has collaborated with scholars based in Jordan, United States and United Kingdom. Frequent co-authors include Bashar Al-Taani, Nida Alshraiedeh, Nusaiba K. Al‐Nemrawi, Tamam El‐Elimat, Sahar Hawamdeh, Barry L. Sharp, George D.D. Jones, Anne Thomas, Tamer Shoeib and Sarah E. Taylor. Their work appears in journals such as Molecules, Heliyon, Pharmaceuticals, International Journal of Mass Spectrometry and Medicinal Chemistry Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.